FDA Approves Eticovo (etanercept-ykro), a Biosimilar to Enbrel

Article Link: FDA Approves Eticovo (etanercept-ykro), a Biosimilar to Enbrel

INCHEON, Korea – As of April 2019 – Samsung Bioepis Co., Ltd. today announced that the US Food and Drug Administration (FDA) has approved Eticovo (etanercept-ykro), a biosimilar referencing Enbrel (etanercept), across all eligible…

Source: FDA New Drug Approvals